Abbott Laboratories (BIT:1ABT)

Market Cap	179.49B
Revenue (ttm)	37.75B
Net Income (ttm)	5.56B
Shares Out	n/a
EPS (ttm)	3.17
PE Ratio	32.30
Forward PE	21.16
Dividend	2.15 (2.08%)
Ex-Dividend Date	Jan 14, 2026

Volume	n/a
Average Volume	161
Open	102.98
Previous Close	105.26
Day's Range	102.98 - 102.98
52-Week Range	102.98 - 120.94
Beta	n/a
RSI	36.29
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ABT

Financial Performance

In 2025, Abbott Laboratories's revenue was $44.33 billion, an increase of 5.67% compared to the previous year's $41.95 billion. Earnings were $6.52 billion, a decrease of -51.13%.

Financial numbers in USD